InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Estepan Ian Michael, 首席财务官. Insider active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 24 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €992k. Activity tracked since 8 September 2021. The latest transaction was filed on 4 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Estepan Ian Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
24,799 股@ US$22.22Common StockSEC:0001193125-26-385544:0
1,097 股@ US$17.030.7% 占其流量Common StockSEC:0001193125-26-106710:0
1,036 股@ US$16.950.7% 占其流量Common StockSEC:0001193125-26-102701:0
8,125 股Common StockSEC:0001193125-26-089432:0
2,069 股@ US$13.711.1% 占其流量Common StockSEC:0001193125-26-084265:0
13,187 股@ US$22.3111.4% 占其流量Common StockSEC:0001193125-25-325383:0
93,875 股0Common StockSEC:0001193125-25-197423:0
5,500 股Common StockSEC:0000950170-25-037519:0
17,500 股Common StockSEC:0000950170-25-036695:0
1,370 股@ US$101.346.5% 占其流量Common StockSEC:0000950170-25-035003:0
557 股@ US$103.772.7% 占其流量Common StockSEC:0000950170-25-032760:0
14,267 股@ US$12.008.0% 占其流量Common StockSEC:0000950170-25-011959:0
250 股0Common StockSEC:0000950170-24-141250:0
5,985 股@ US$137.3636.1% 占其流量Common StockSEC:0000950170-24-103070:0
6,250 股Common StockSEC:0000950170-24-077519:0
526 股@ US$120.492.8% 占其流量Common StockSEC:0000950170-24-029529:0
1,389 股@ US$125.327.8% 占其流量Common StockSEC:0000950170-24-027498:0
365 股@ US$126.192.1% 占其流量Common StockSEC:0000950170-24-026605:0
744 股@ US$153.195.3% 占其流量Common StockSEC:0001209191-23-018020:0
1,370 股@ US$157.219.9% 占其流量Common StockSEC:0001209191-23-017408:0
378 股@ US$147.572.6% 占其流量Common StockSEC:0001209191-23-016055:0
1,308 股@ US$79.204.2% 占其流量Common StockSEC:0001209191-22-017347:0
376 股@ US$75.051.1% 占其流量Common StockSEC:0001209191-22-014408:0
1,623 股@ US$78.294.8% 占其流量Common StockSEC:0001209191-21-055383:0
24 条申报中的 24 条
About Estepan Ian Michael
Estepan Ian Michael is Directeur Financier and Chief Operating Officer at Sarepta Therapeutics, Inc. Across 23 filings in total, the 23 sampled filings span from 2021-09-09 to 2026-03-13, with EUR 0 of buys and EUR 992223 of sells, and the modal transaction nature is Retenue fiscale.
